Kyongbo
Since its establishment in 1987, Kyongbo Pharmaceutical has grown into one of Korea’s leading API pharmaceutical companies, supplying raw materials to more than 30 countries at home and abroad. We have successfully achieved a track record in various regulatory agencies around the world, including the FDA, EDQM, PMDA, CFDA, and MFDS.
We have expanded our business into the field of ADCs, providing CDMO services. We provide integrated services for ADCs, from payloads production to linker production and conjugation development. As a trusted CDMO partner, we provide integrated CDMO services for ADCs production to meet the needs of clients.
